Research output per year
Research output per year
-
201 Bone safety data in adolescents with moderate-to-severe atopic dermatitis treated with abrocitinib: interim results from the JADE EXTEND MRI substudy
Zdybski, J., Wollenberg, A., Flohr, C., Brunner, P. M., Högler, W., Egeberg, A., Irvine, A. D., Fan, H. H., Biswas, P., Radivojevic, Z., Farooqui, S. A., Koppensteiner, H., Sherlock, S. P. & Chan, G., 2024, In: JID. 1 p.Research output: Contribution to journal › Article › peer-review
-
A perspective on muscle phenotyping in musculoskeletal research
Foessl, I., Ackert-Bicknell, C. L., Kague, E., Laskou, F., Jakob, F., Karasik, D., Obermayer-Pietsch, B., Alonso, N., Bjørnerem, Å., Busse, B., Calado, Â., Cebi, A., Christou, M., Curran, K., Hald, J., Semeraro, M., Douni, E., Duran, I., Formosa, M. M. & Gabet, Y. & 33 others, , Jun 2024, In: Trends Endocrinol Metab. 35, 6, p. 478-489 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Beyond Vitamin D: Elevated Parathyroid Hormone is associated with inferior event-free survival in childhood malignancies
Grasemann, C., Höppner, J., Högler, W., Tippelt, S., Grabow, D., Cario, G., Schrappe, D., Reinhardt, D. & Schündeln, M. M., 2024, In: JBMR Plus. 1 p.Research output: Contribution to journal › Article › peer-review
-
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: Results of the open-label, phase 3 extension period
Ward, L., Högler, W., Glorieux, F., Portale, A., Whyte, M., Munns, C., Nilsson, O., Simmons, J., Padidela, R., Namba, N., Cheong, H., Sochett, E., Muroya, K., Tanaka, K., Pitukcheewanont, P., Gottesman, G., Biggin, A., Perwad, F., Chen, M. & Merritt , L. & 1 others, , Jan 2024, In: JBMR Plus. 8, 1, 1 p., ziad001.Research output: Contribution to journal › Article › peer-review
Open Access -
Challenges in Hypophosphatasia: Suspicion, Diagnosis, Genetics, Management, and Follow-Up
Montero-Lopez, R., Farman, M., Högler, F., Saraff, V. & Högler, W., 2024, In: Horm Res Paed. 1 p.Research output: Contribution to journal › Article › peer-review
-
Alkohol-, Drogen- und Mischintoxikationen bei Minderjährigen - eine retrospektive Analyse der letzten 5 Jahre am Standort KUK MC4
Breiteneder, M. (Researcher) & Högler, W. (PI)
15.12.2024 → 31.12.2025
Project: Other › Master thesis project
-
Calcification Propensity Index
Weixelbaumer, J. (Researcher) & Högler, W. (PI)
15.12.2024 → 31.12.2025
Project: Other › Master thesis project
-
reACHin: A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-controlled Trial, evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 52 Weeks in Infants (0 to <2 years of age) with Achondroplasia followed by an Open Label Extension (OLE) period
Montero-Lopez, R. (Researcher) & Högler, W. (PI)
30.06.2024 → 31.12.2030
Project: Clinical studies › Clinical Study (Industry project)
-
BODIA CROSSEC: Early Identification of Structural Bone Deficits in Children and Young People with Type 1 Diabetes: A Cross-Sectional Study of the “BODIA LINZ” Cohort"
Gabriel, M. (Researcher), Montero-Lopez, R. (Researcher) & Högler, W. (PI)
31.12.2023 → 31.12.2025
Project: Other › Project from scientific scope of research unit
-
AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia
Hörtenhuber, T. (Researcher), Montero-Lopez, R. (Researcher), Tischlinger, K. (Researcher) & Högler, W. (PI)
06.12.2023 → 31.12.2030
Project: Clinical studies › Clinical Study (Industry project)
Activities
-
New clinical phenotypes associated with ALPL mutations
Farman, M. (Speaker), Rehder, C. (Speaker), Rockman-Greenberg, C. (Speaker), Malli, T. (Speaker), Dahir, K. (Speaker), Linglart, A. (Speaker), Ozono, K. (Speaker), Seefried, L. (Speaker), del Angel, G. (Speaker), Högler, F. (Speaker), Montero-Lopez, R. (Speaker), Barbazza, F. (Speaker), Burner Nading, E. (Speaker), Huggins, E. (Speaker), Rush, E. (Speaker), Tauer, J. (Speaker), Kishnani, P. (Speaker), Webersinke, G. (Speaker) & Högler, W. (Speaker)
18 Nov 2024Activity: Talk or presentation › Poster presentation › science-to-science
-
Comprehensive analysis of disease spectrum and mortality in Sanjad-Sakati Syndrome: A Rare Disease Perspective
Laurer, E. (Speaker), Rohayem, J. (Speaker), Heger, S. (Speaker), Högler, W. (Speaker), Rey, R. (Speaker) & Howard, S. (Speaker)
16 Nov 2024Activity: Talk or presentation › Poster presentation › science-to-science
-
New clinical phenotypes associated with ALPL mutations
Farman, M. (Speaker), Rehder, C. (Speaker), Malli, T. (Speaker), Rockman-Greenberg, C. (Speaker), Dahir, K. (Speaker), Martos-Moreno, G. Á. (Speaker), Linglart, A. (Speaker), Ozono, K. (Speaker), Seefried, L. (Speaker), del Angel, G. (Speaker), Högler, F. (Speaker), Montero-Lopez, R. (Speaker), Barbazza, F. (Speaker), Burner Nading, E. (Speaker), Rush, E. (Speaker), Muhammad, K. J. (Speaker), Tauer, J. (Speaker), Kishnani, P. (Speaker), Webersinke, G. (Speaker) & Högler, W. (Speaker)
16 Nov 2024Activity: Talk or presentation › Poster presentation › science-to-science
-
Osteoporosis in children with chronic illness
Högler, W. (Speaker)
08 Nov 2024Activity: Talk or presentation › Invited talk › science-to-science
-
Neurofibromatose Typ 1 - Überblick über Symptome und Therapieoptionen
Högler, W. (Speaker)
17 Oct 2024Activity: Talk or presentation › Other talk or presentation › science-to-science